Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Silvia Puglisi
Observed names:
Puglisi S.,
Puglisi, Silvia,
S. Puglisi,
Silvia PUGLISI
Institutions:
Ospedale Policlinico San Martino,
IRCCS Azienda Ospedaliera Metropolitana,
University of Genoa
Observed institutions:
Ospedale Garibaldi,
Istituto Oncologico Veneto,
Ospedale Policlinico San Martino,
Istituti di Ricovero e Cura a Carattere Scientifico,
IRCCS Azienda Ospedaliera Metropolitana,
University of Genoa
show all 6
ORCID:
0000-0001-9318-6358
Observed ORCID:
0000-0001-9318-6358
OpenAlex ID:
A5044338935
The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives
2023
·
Annalice Gandini
, Silvia Puglisi
, et al.
·
Frontiers in Oncology
·
50
PDF
Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer
2022
·
Fabio Catalano
, Roberto Borea
, et al.
·
Cancers
·
50
PDF
Approaches to Fertility Preservation for Young Women With Breast Cancer
2023
·
Maria G. Razeti
, Davide Soldato
, et al.
·
Clinical Breast Cancer
·
35
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients
2022
·
Alberto Puccini
, Marta Ponzano
, et al.
·
Cancers
·
35
PDF
Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis
2021
·
Ludovica Mollica
, Claudia Leli
, et al.
·
Drugs in Context
·
29
PDF
Ovarian Suppression: Early Menopause and Late Effects
2024
·
Chiara Molinelli
, Flavia Jacobs
, et al.
·
Current Treatment Options in Oncology
·
28
PDF
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma
2022
·
Sebastiano Buti
, Chiara Tommasi
, et al.
·
Anti-Cancer Drugs
·
16
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25)
2024
·
Elisabetta Gambale
, Marco Maruzzo
, et al.
·
Clinical Genitourinary Cancer
·
12
PDF
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer
2023
·
Malvina Cremante
, Silvia Puglisi
, et al.
·
Journal of Oncology Pharmacy Practice
·
9
A Comprehensive Approach to Neoadjuvant Treatment of Locally Advanced Rectal Cancer
2025
·
Annalice Gandini
, Stefania Sciallero
, et al.
·
Cancers
·
8
PDF
Immune checkpoint inhibitors in gynecological cancers: a narrative review on the practice-changing trials
2025
·
Cecilia Nasso
, Silvia Puglisi
, et al.
·
Immunotherapy
·
8
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score
2023
·
Giulia Mazzaschi
, Alessandro Lazzarin
, et al.
·
Frontiers in Bioscience-Elite
·
8
PDF
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score
2022
·
Giuseppe FORNARINI
, Sara E. REBUZZI
, et al.
·
Minerva Urology and Nephrology
·
8
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study
2023
·
Chiara Tommasi
, Giulia Scartabellati
, et al.
·
Therapeutic Advances in Urology
·
7
PDF
Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25)
2025
·
Giandomenico Roviello
, Elisabetta Gambale
, et al.
·
The Oncologist
·
5
PDF
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer
2024
·
Marzia Del Re
, Stefania Crucitta
, et al.
·
Clinical Genitourinary Cancer
·
5
Reliability of patient-reported toxicities during adjuvant chemotherapy
2023
·
Malvina Cremante
, Alessandro Pastorino
, et al.
·
European Journal of Cancer
·
5
Durable Response after Immunotherapy Discontinuation for Delayed and Severe Immune-related Adverse Event: A Case Report
2021
·
Guido Pesola
, Veronica Murianni
, et al.
·
Immunotherapy
·
5
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients
2024
·
Francesca Parisi
, Giuseppa De Luca
, et al.
·
Cancer Treatment and Research Communications
·
4
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?
2023
·
Matilde Corianò
, Diana Giannarelli
, et al.
·
Expert Review of Anticancer Therapy
·
4
Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study
2024
·
Brigida Anna Maiorano
, Martina Catalano
, et al.
·
Clinical Genitourinary Cancer
·
3
Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer
2024
·
A. Gandini
, V. Martelli
, et al.
·
ESMO Gastrointestinal Oncology
·
2
PDF
Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered?
2023
·
Diletta Favero
, Laura Sabina Lapuchesky
, et al.
·
Expert Opinion on Pharmacotherapy
·
2
Basal cell carcinoma of the prostate: a case report of a rare prostate cancer and review of the literature
2023
·
Silvia Puglisi
, Malvina Cremante
, et al.
·
Acta bio-medica dell'Ateneo parmense/Acta biomedica
·
2
PDF
The controversial abscopal effect: A single-center experience about the combination of stereotactic radiotherapy with pembrolizumab in patients with metastatic dMMR/MSI-H colorectal cancer.
2023
·
Annalice Gandini
, Valentino Martelli
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Show more works
View as search
Works count:
46
Citation count:
347
H-index:
9
I10-index:
8
Year
Topic
Type